Trial Profile
Effect of glatiramer acetate and dimethyl fumarate on the gut micro-biota and immune responses in patients with Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2017
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 04 May 2017 New trial record
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology